SUBSCRIBE
SUBSCRIBE

Phase I

Alnylam Stock Craters After Deaths Cause Clinical Trial to End
Drug Development
Alnylam’s John Maraganore Provides Leadership for RNAi Development and Biotech Industry
April 1, 2016
 · 
7 min read
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
 · 
3 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
TauRx Pharma Co-Founder’s 30-Year Alzheimer’s Quest May Bear Fruit in July
March 18, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
AbbVie Coughs Up $595 Million+ for Boehringer Ingelheim’s Psoriasis and Crohn’s Drugs
March 7, 2016
 · 
2 min read
Drug Development
Kite Pharma’s CEO On Cancer-Killing T-Cells: “This Is A Revolution”
February 29, 2016
 · 
1 min read
Drug Development
Pharma’s Big New Cancer Drug May Be An Old Red Dye
February 26, 2016
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Bial’s Fatal Clinical Trial in France Had Already Caused Deaths of Dogs in Earlier Tests
February 26, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Orphan Drug Designation Status for Acerta Pharma Drug Vindicates AstraZeneca PLC’s $4 Billion Deal
February 25, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AstraZeneca PLC Continues Its Immuno-Oncology Roll, Durvalumab Gets Breathrough Designation for Bladder Cancer
February 17, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Armed with $50 Million from Google, Celgene and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos
February 10, 2016
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Trellis Bioscience Announces Positive Interim Phase 1 Results for TRL1068, a Novel Native Human Monoclonal Antibody Which Reduces Bacterial Biofilm Burden in Chronic Prosthetic Joint Infections
May 4, 2023
 · 
7 min read
Drug Development
Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa
May 4, 2023
 · 
3 min read
Drug Development
Incannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
May 3, 2023
 · 
1 min read
Drug Development
Zevra Therapeutics Announces FDA Acceptance of IND Application for KP1077 in Narcolepsy
May 3, 2023
 · 
6 min read
Drug Development
EirGenix’s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives
May 2, 2023
 · 
3 min read
Drug Development
Verismo Therapeutics Announces the Activation of its STAR-101 Clinical Trial at the University of Pennsylvania
May 2, 2023
 · 
3 min read
Drug Development
Moleculin Successfully Completes First Cohort in Phase 1b/2 Trial Evaluating Annamycin in Combination with Cytarabine (Ara-C) for the Treatment of Acute Myeloid Leukemia (AML)
May 2, 2023
 · 
6 min read
Drug Development
Scorpion Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of STX-478, Its Mutant-Selective PI3Kα Inhibitor for the Treatment of Breast Cancer and Other Solid Tumors
May 2, 2023
 · 
5 min read
Drug Development
Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
May 1, 2023
 · 
7 min read
Drug Development
Kiromic BioPharma Announces FDA Authorization of IND to Initiate Phase 1 Clinical Trial Evaluating Deltacel in Non-Small Cell Lung Cancer
May 1, 2023
 · 
4 min read
Drug Development
Elicio Therapeutics to Present Interim Data from the Ongoing Phase 1 Study of Investigational Therapeutic Cancer Vaccine, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at ASCO
May 1, 2023
 · 
10 min read
Drug Development
Atsena Therapeutics Receives FDA Clearance of IND Application for ATSN-201, an Investigational Gene Therapy for the Treatment of X-linked Retinoschisis
May 1, 2023
 · 
4 min read
Drug Development
Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
April 28, 2023
 · 
10 min read
Drug Development
Protara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development
April 28, 2023
 · 
8 min read
Drug Development
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
April 28, 2023
 · 
5 min read
Drug Development
Avidity Biosciences Announces Positive Topline Data from AOC 1001 Phase 1/2 MARINA™ Trial Demonstrating Functional Improvement, Disease Modification and Favorable Safety and Tolerability Profile in People Living with Myotonic Dystrophy Type 1
April 27, 2023
 · 
13 min read
Drug Development
RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine
April 27, 2023
 · 
3 min read
Drug Development
Skye Bioscience Begins Dosing Phase 1 Fourth Cohort in Clinical Trial of Novel CB1R Agonist
April 27, 2023
 · 
5 min read
Drug Development
Elicio Therapeutics Announces First Patient Dosed in Phase 1/2 Study of Lymph Node-Targeted Investigational Therapeutic Vaccine ELI-002 7P (AMPLIFY-7P) in KRAS/NRAS Mutated Solid Tumors
April 27, 2023
 · 
11 min read
Drug Development
First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
April 27, 2023
 · 
1 min read
Load More